---
title: "LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 8-K: FY2025 Q1 Revenue: USD 65.7 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238979881.md"
datetime: "2025-05-06T20:12:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238979881.md)
  - [en](https://longbridge.com/en/news/238979881.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238979881.md)
---

# LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 8-K: FY2025 Q1 Revenue: USD 65.7 M

Revenue: As of FY2025 Q1, the actual value is USD 65.7 M.

EPS: As of FY2025 Q1, the actual value is USD 0.01.

EBIT: As of FY2025 Q1, the actual value is USD 2.543 M.

### Segment Revenue

-   **Total Revenue**: $65.7 million, a 49% increase year-over-year.
-   **Telehealth Revenue**: $52.5 million, a 70% increase year-over-year.
-   **WorkSimpli Revenue**: $13.2 million, unchanged from the previous year.

### Operational Metrics

-   **Net Income**: $0.6 million, compared to a net loss of - $7.5 million in the previous year.
-   **Gross Margin**: 87%, down from 90% due to revenue mix and the launch of LifeMD’s pharmacy.
-   **Adjusted EBITDA**: $8.7 million, up from $0.1 million in the previous year.
-   **Telehealth Adjusted EBITDA**: $5.3 million, compared to a loss of - $1.3 million in the previous year.

### Cash Flow

-   **Cash**: $34.4 million as of March 31, 2025.

### Unique Metrics

-   **Telehealth Active Subscribers**: Increased 22% to approximately 290,000.
-   **Total Active Subscribers**: Increased 11% to 448,925.

### Outlook / Guidance

-   LifeMD raised its full-year 2025 guidance for total revenues to $268-$275 million and adjusted EBITDA to $31-$33 million, reflecting strong performance in telehealth.
-   For the second quarter of 2025, expected total revenues are $65-$67 million, with telehealth revenue of $52-$53 million.

### Related Stocks

- [LFMDP.US](https://longbridge.com/en/quote/LFMDP.US.md)

## Related News & Research

- [Meet the Dividend King That's Quietly Crushing the S&P 500 in 2026. Here's Why It's a Buy This August.](https://longbridge.com/en/news/296262501.md)
- [Warren Buffett's Successor, Greg Abel, Has 34.7% of Berkshire Hathaway's Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks](https://longbridge.com/en/news/296274565.md)
- [ANET, SPOT, HOOD: 3 Best Growth Stocks to Buy This Week, According to Analysts](https://longbridge.com/en/news/296275933.md)
- [As retail stagnates, ad dollars help Walmart stay the course](https://longbridge.com/en/news/296209943.md)
- [Kalshi files for S&P 500 perpetual futures in challenge to traditional exchanges](https://longbridge.com/en/news/296226910.md)